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︿原著﹀
Computer-aided automated evaluation of MAML2 and EWSR1 
rearrangements in five cases of mucoepidermoid carcinoma: A 
single-institution study using fluorescence in situ hybridization
Kenji Yorita1, Naoto Kuroda1, Yoshiko Agatsuma1, Yukari Wada1, Masahiko Ohara1, 
Kaori Yasuoka1, Keiko Mizuno1, Junya Fukuda2, Hideyuki Nakagawa2, 
Katsushi Miyazaki2, Nobuyuki Tanida3, Nobumasa Hamaguchi3
Abstract : Background: Mucoepidermoid carcinoma (MEC) is the most common malignant salivary gland 
tumor. Histological diagnosis of MECs that exhibit classical histological features is not difficult. However, 
diagnosis of some histological variants or high-grade MEC tumors can be challenging because of overlaps 
in histological features with other diseases. Recently, chromosomal translocations in salivary gland 
tumors have been recognized, and the detection of MAML2 rearrangements can support the pathological 
diagnosis of MECs. Recently, MECs without MAML2 rearrangements might be reclassified as hyalinizing 
clear cell carcinoma (HCCC) based on the detection of EWSR1-ATF1 gene fusions. The present study 
aimed to investigate the presence of MAML2 and EWSR1 rearrangements in MECs via fluorescence in 
situ hybridization (FISH). 
Materials and methods: We retrospectively analyzed tumor samples from five MEC patients diagnosed in 
our hospital between 2008 to 2015. A total of six tumors from the five cases were pathologically evaluated 
and subjected to FISH analysis, which was performed using a MetaSystems image analysis system. 
Results: The median age of the patients was 75 years (range: 32-79), with the majority of patients 
being male (male to female ratio, 4:1). The localization and pathological classification (histological 
grade, histological variant) of the six tumors were parotid gland/low grade/classical histology (n=2), 
submandibular gland/low grade/clear cell variant (n=1), lung/high grade (n=1), lung/low grade/classical 
(n=1), and maxillary sinus/low grade/clear cell variant (n=1). Less than 10% of the background non-
neoplastic cells showed split signals of MAML2. Positive MAML2 rearrangements were observed in two 
parotid tumors and one maxillary sinus tumor because each tumor showed over 90% of MAML2 split 
signals. The other tumors appeared to show equivocal results for MAML2 rearrangement. No EWSR1 
rearrangements were detected in all cases, suggesting that HCCC was not present. 
Conclusion: FISH was found to be effective for obtaining conclusive MEC diagnoses with small biopsy 
samples. However, this method may have a high rate of returning equivocal results, thereby limiting its 
use in confirming the presence of gene rearrangements. 
Keywords : Mucoepidermoid carcinoma, MAML2 rearrangement, EWSR1 rearrangement, fluorescence in situ 
hybridization
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Introduction
Mucoepidermoid carcinoma (MEC) is the most 
common malignant salivary gland tumor affecting 
children and young adults. MEC is characterized 
by cyst ic  and so l id growth of  mucinous , 
intermediate, and squamous tumor cells.1 MECs 
have variable histological subtypes, including the 
oncocytic, clear-cell, and sclerosing variants. MECs 
are classified into three histological grades, namely, 
low, intermediate, and high.1 High-grade MECs 
are more aggressive than low- to intermediate-
grade MECs.1 The presence of typical histological 
features of MEC usually leads to the correct 
diagnosis. However, histological variants and high-
grade MECs can be difficult to diagnose because 
of overlaps in histological features with other 
tumor types. For example, the characteristics of 
high-grade MECs can be very similar to those of 
adenosquamous carcinoma.
The presence of chromosomal translocations 
in MECs was first reported by Tonon et al. in 
2003.2 Most MECs are genetically characterized 
by a t(11;19)(q21;p13) translocation and a CRTC1-
MAML2 gene fusion, t(11;15)(q21;q26) translocation 
and CRTC3-MAML2  gene fusion, or t(6;22)
(p21;q12) translocation and EWSR1-POU5F1 gene 
fusion.1 The translocation generating a CRTC1-
MAML2 fusion gene is detected in 34% to 82% 
of MECs, with an average detection rate of 52% 
(356/679 cases).3-13 Other translocations are rare, 
and a recent study reported only a 6% incidence 
of CRTC3-MAML2-positive MECs (6/101 cases).14 
Recently, EWSR1-ATF1 gene fusion has been 
recognized as a novel marker for hyalinizing clear 
cell carcinoma (HCCC) in the salivary glands.15 
HCCC is characterized by sheets or nests of clear, 
glycogen-rich tumor cells and is histologically 
s im i l a r  t o  MEC because  o f  h i gh  muc in 
production.16 MAML2 fusion-negative MECs may 
be reclassified as HCCC if the tumors are positive 
for EWSR1-ATF1 gene fusion.16 
The fusion status can serve as a reliable 
prognostic marker for detecting MECs because 
CRTC1-MAML2 fusion-positive MECs tend to be 
low to intermediate grade and have lower risk of 
local recurrence, metastases, disease-free survival, 
or tumor-related death than those of fusion-
negative MEC.4, 7-12, 17 Moreover, CRTC1-MAML2 
and CRTC3-MAML2 often remain undetected 
in normal salivary glands and other salivary 
gland tumors.3, 5, 7, 17, 18 Thus, detection of MAML2 
rearrangements is expected to be useful for MEC 
diagnosis. Fluorescence in situ hybridization 
(FISH) and reverse transcriptase-polymerase chain 
reaction (RT-PCR) have been used for detecting 
MAML2 rearrangements. Previous FISH studies 
have shown that tumors with MAML2 split signal 
cut-offs ranging from 10% to 20% are classified as 
MEC;3, 7, 19 and cut-off values for defining positive 
gene rearrangements have not been established 
for FISH. 
In the present study, we performed FISH to 
evaluate the presence of MAML2 and EWSR1 
rearrangements in samples from MEC patients 
diagnosed or treated in our hospital .  The 
diagnostic value of FISH for MEC detection was 
evaluated using a MetaSystems image analysis 
system.
Materials and Methods
This case study was approved by Japanese 
Red Cross Kochi Hospital Institutional Review 
Board (No. 218). We retrospectively analyzed five 
MEC cases diagnosed or surgically diagnosed in 
the Japanese Red Cross Kochi Hospital between 
2008 and 2015. A total of six tumors from the five 
cases were clinicopathologically and genetically 
evaluated. Schwarz et al. classified tumors as 
'classical' based on equal proportions of the three 
cell types or the dominance (≥ 50%) of mucous 
cells together with at least one other cell type.8 
On the other hand, tumors were classified as 
‘variant’ if ≥ 80% of the tumors were single non-
mucous cell type.8 The histological grading system 
of MEC given by Goode et al. was used.20 In case 
5, HCCC and epithelial-myoepithelial carcinoma 
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Table 1. Clinical data of the five mucoepidermoid carcinoma cases.
Case Age/Sex Tumor location
Maximum 
size
UICC Stage 
at diagnosis Treatment
Metastasis/
recurrence
Follow-up 
(months)
1 32/M Parotid gland 32 mm NA Surgery NA NA
2 74/M Parotid gland 12 mm T1N0M0 Surgery No AWOD (27)
3 79/F Maxillary sinus 70 mm T4N0M0 Palliative care No AWD (8)
4 75/M Submandibular gland 25 mm T2N0M0
Surgery, and 
postoperative 
radiotherapy (total 50 Gy)
No AWOD (53)
5 76/M
Lung, left upper 
(main tumor) 50 mm
T4N0M1
Surgery, and 
postoperative 
chemotherapy 
Lung metastasis present 
at surgery and lung 
recurrence was present 
after surgery
DOD (66)
S8 tumor
 (metastatic lesion) 10 mm
Abbreviations: M, male; F, female; UICC, Union for International Cancer Control; NA, not available; Gy, gray; AWOD, alive 
without disease; DOD, died of disease; AWD, alive with disease 
were candidates for diagnosis, and a conclusive 
diagnosis could not be made without FISH. 
FISH for MAML2 and EWSR1 and automated 
analysis of the FISH signals
We performed FISH analysis for MAML2 and 
EWSR1 gene rearrangements. Formalin-fixed and 
paraffin-embedded (FFPE) tumors, which had been 
prepared from five surgically resected tumors 
and one biopsy sample, were cut into 4-µm-thick 
sections, placed on glass slides, pre-treated with 
a VP-2000 Processor (Abbott Molecular, Tokyo, 
Japan), and incubated with a MAML2 Dual-Color 
Break-Apart Probe (ZytoVision, Bremerhaven, 
Germany) or an LSI EWSR1 Dual-Color Break-
Apart Probe (Abbott Molecular, Des Plaines, 
IL, USA). Hybridization was performed using a 
ThermoBrite system (Abbott Molecular, Tokyo, 
Japan). Slides were placed in a post-hybridization 
wash solution, counterstained with DAPI (Vysis, 
Inc., Downers Grove, IL, USA), and examined 
immediately after processing. Fluorescence 
images were obtained using an Axio Imager 2 
Upright Microscope (Zeiss, Tokyo, Japan). Data 
were automatically analyzed using the Metafer 
4 version 3.10.4 imaging system (MetaSystems, 
Altlussheim, Germany). At least 100 nuclei were 
automatically scored. Cells with two fusion signals 
(one orange and one green fluorochrome) were 
defined as normal. Cells harboring MAML2 
rearrangements had one normal fusion signal, one 
orange, and one green signal.
Results
Clinicopathological data from the five patients 
are summarized in Tables 1 and 2. The median 
age of the patients was 75 years (age range; 32-79). 
Five tumors were classified as low-grade MECs, 
while one tumor was classified as high-grade MEC. 
In three low-grade MECs (two parotid MECs and 
one maxillary sinus MEC), over 90% of the tumor 
cells showed split signals of MAML2 with FISH 
(Figure 1) and were thus considered positive 
for MAML2 rearrangement. In the other three 
MECs, 17% to 20% of the tumor cells showed split 
signals, which was considered as equivocal based 
on internal validation of the background non-
neoplastic tissues and a previously reported cut-
off value of MECs.7 MAML2 rearrangement was 
not detected in the high-grade pulmonary MEC. 
No EWSR1 rearrangements were detected in all 
cases. 
Discussion
In the present study, FISH was conducted 
to evaluate the chromosomal abnormalities in 
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MAML2 and EWSR1 genes in five MEC cases. 
Based on FISH results, three MECs showed high 
rates (> 90%) of split signals in the MAML2 gene 
and were thus considered positive for MAML2 
rearrangement. The FISH method significantly 
contributed to obtaining conclusive diagnosis of 
the maxillary sinus tumor (case 5), which could not 
be diagnosed using biopsy specimens.
Consistent with the results of previous studies, 
all tumors that were positive for MAML2 
rearrangement were low-grade tumors. The rate 
for positive MAML2 rearrangement in salivary 
gland MECs was higher in low- or intermediate-
grade tumors than that in high-grade tumors [low 
grade, 57% (169/298 cases); intermediate grade, 
48% (35/73 cases); high grade, 23% (38/164 cases)].4, 
7-12 Similar results were obtained for pulmonary 
MECs [low to intermediate grade 60% (33/55 
cases) and high grade 23% (5/22 cases)].17, 19, 21 In a 
previous study on adenosquamous carcinoma, all 
36 cases did not show MAML2 rearrangement. 
Thus, although high-grade MECs had low rates of 
Table 2. Pathological data of the five mucoepidermoid carcinoma cases.
Case MEC, histological subtype
Cystic 
component 
<20%
Neural 
invasion Necrosis
Four or more 
mitoses/10 HPFs Anaplasia
Histological 
grade
MAML2
FISH (rate of 
split signals)
1 Classical No (30%) Present Absent Absent (1/10 hpf) Absent Low grade 94%
2 Classical, TALP present No (30%) Absent Absent Absent (1/10 hpf) Absent Low grade 94%
3 Clear cell variant Yes (0%) Absent Absent Absent (0/10 hpf) Absent Low grade 98%
4 Clear cell variant Yes (10%) Present Absent Absent (1/10 hpf) Absent Low grade 17%
5
Main lung tumor: 
squamoid variant Yes (<5%) Absent Present present (8/10 hpf) Present High grade 20%
S8 tumor and 
recurrent tumors: 
classical
Yes (0%) Absent Absent Absent (<3/10 hpf) Absent Low grade 18%
Abbreviations: MEC, mucoepidermoid carcinoma; TALP, tumor-associated lymphoid proliferation; hpf, high power field; 
FISH, fluorescence in situ hybridization
Figure 1. Histological and fluorescence in situ hybridization results for a classical, low-grade 
mucoepidermoid carcinoma.
A. Hematoxylin-and-eosin staining of a classical, low-grade mucoepidermoid carcinoma showing a mixture 
of mucinous, intermediate, and/or squamoid cells (400×). B. Fluorescence in situ hybridization of the 
MAML2 gene shows that most tumor cells have split signals, including isolated red signals and green 
signals. The inset shows a typical split signal in a tumor nucleus. 
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MAML2 rearrangement, further genetic studies 
on high-grade MECs will be useful to distinguish 
between high-grade MECs and adenosquamous 
carcinoma.17, 22 Seethala et al. suggested that 
translocation-negative high-grade MECs may be 
more appropriately categorized as a different 
tumor type, such as adenosquamous carcinoma.7 
The clear cell variant of MECs shows a high 
frequency of MAML2 rearrangement,8 and one of 
two MECs classified under the clear cell variant 
in our study was positive for gene rearrangement. 
However, further study with a higher number of 
cases will be required.
In the present study, less than 10% of the 
background non-neoplastic cells showed split 
signals of MAML2, suggesting that three MECs 
with a split signal rate of 17% to 20% were 
positive for MAML2 rearrangement. However, the 
split signal rate of these three MECs was notably 
lower than that of the other three MECs; previous 
FISH studies have shown that tumors with an 
MAML2 split signal cut-off of 20% are classified 
as MEC.7 Thus, the equivocal results of our study 
were validated, and we suggest that intratumoral 
heterogeneity might be present in these tumors. 
Further validation with other techniques, such as 
RT-PCR, will be required if equivocal results are 
obtained with FISH. 
Detection of MAML2  rearrangements is 
expected to contribute to histological diagnosis 
of MECs. However, Warthin tumors can also be 
positive for MAML2 rearrangements. Tirado 
et al. reported that 36% (4/11 cases) of Warthin 
tumors were positive for CRTC1-MAML2 fusion 
transcript based on RT-PCR.5 On the other hand, 
Seethala et al. reported that none of 24 cases of 
Warthin tumor in their sample were negative for 
the translocation based on FISH and RT-PCR 7. 
Fehr et al. reported that tumors with the t(11;19)
(q21;p13) rearrangement favored a diagnosis of 
MEC rather than Warthin tumor because fusion-
positive Warthin tumors could be reclassified as 
MEC.18 Rotellini et al. suggested that MAML2 
fusion-positive Warthin tumors represented a 
molecular link between the two entities because 
fusion-posit ive Warthin tumors presented 
squamous metaplasia.23 Thus, pathologists should 
consider a diagnosis for Warthin tumor even if 
the translocation is present in MECs. In our study, 
Warthin tumors were not included in all cases.
No EWSR1 rearrangements were detected, 
suggesting that HCCC was not included in our 
cases. Hsieh et al. reported that 18% (3/17 cases) 
of MAML2-fusion-negative MEC tumors could be 
reclassified as HCCC with confirmation of EWSR1-
ATF1 fusion and proposed that MEC cases arising 
from minor salivary glands or without MAML2 
fusion should be distinguished from HCCC.16
Conclusion
The use o f  FISH in detect ing MAML2 
rearrangements is effective for obtaining a 
conclusive MEC diagnosis using small biopsy 
specimens. However, MAML2 FISH might be less 
effective for confirming the presence of MAML2 
rearrangements in FFPE blocks of MEC tumors.
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